Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions

被引:66
|
作者
Lee, Jin Gu [1 ]
Shin, Ju Hye [2 ]
Shim, Hyo Sup [3 ]
Lee, Chang Young [1 ]
Kim, Dae Joon [1 ]
Kim, Young Sam [2 ]
Chung, Kyung Young [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea
来源
RESPIRATORY RESEARCH | 2015年 / 16卷
关键词
Autophagy; Chemotherapy; Hypoxia; Lung cancer; Resistance; DECREASED EXPRESSION; TUMOR HYPOXIA; SURVIVAL; BECLIN-1; PROLIFERATION; PROTEINS; BNIP3; HIF-1; LC3;
D O I
10.1186/s12931-015-0285-4
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The development of chemo-resistance in non-small lung cancer is a major obstacle in treating patients. Hypoxia is a commonly faced microenvironment in solid tumor and suggested to be related to both autophagy and chemo-resistance. Methods: In this study, we investigated the role of hypoxia-induced autophagy in acquiring chemo-resistance in both cancer cell (A549) and human cancer tissue Results: Hypoxic exposure (1 % O2) of A549 cell stimulated autophagic induction in cancer cells, shown by increase of LC3BI to LC3BII conversion and decrease of p62/sequestosome1 in Western blot, increased GFP-LC puncta in confocal microscopy, and increased number of double-membrane autophagic vacuoles in electron micrographs. Hypoxic exposure also induced resistance of cancer cells to cisplatin, and LC3B siRNA restored the sensitivity of cancer cells to chemotherapy. Furthermore, Human lung cancer tissues that experienced chemotherapy showed increase of LC3BI to LC3BII conversion and decrease of p62/sequestosome1 compared with chemo-naive cancer tissue in Western blot. Conclusion: Autophagy may play an important role in acquiring resistance to chemotherapy in lung cancer and hypoxia related pathway seems to be involved in autophagy induction.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions
    Jin Gu Lee
    Ju Hye Shin
    Hyo Sup Shim
    Chang Young Lee
    Dae Joon Kim
    Young Sam Kim
    Kyung Young Chung
    Respiratory Research, 16
  • [2] ELUCIDATING INFLAMMATORY MEDITATED MECHANISMS OF INTRINSIC AND ACQUIRED CHEMO-RESISTANCE IN NON-SMALL CELL LUNG CANCER
    Baird, Anne-Marie
    Ryan, Sarah-Louise
    Godwin, Peter
    Heavey, Susan
    Umezawa, Kazuo
    Barr, Martin
    Gray, Steven
    Davies, Anthony
    Richard, Derek
    Gately, Kathy
    O'Byrne, Kenneth J.
    Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 112 - 113
  • [3] Utilization of a Novel 3D Culture Technology for the Assessment of Chemo-Resistance in Non-Small Cell Lung Cancer
    Ryan, Sarah-Louise
    Baird, Anne-Marie
    Lu, Z.
    Urquhart, Aaron
    Barr, Martin
    Richard, Derek
    O'Byrne, Kenneth
    Davies, Anthony
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S994 - S995
  • [4] Critical contribution of MCL-1 in EMT-associated chemo-resistance in A549 non-small cell lung cancer
    Toge, Masayoshi
    Yokoyama, Satoru
    Kato, Shinichiro
    Sakurai, Hiroaki
    Senda, Kazutaka
    Doki, Yoshinori
    Hayakawa, Yoshihiro
    Yoshimura, Naoki
    Saiki, Ikuo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (04) : 1844 - 1848
  • [5] Autophagy regulates resistance of non-small cell lung cancer cells to paclitaxel
    Chen, Kan
    Shi, Wenjun
    TUMOR BIOLOGY, 2016, 37 (08) : 10539 - 10544
  • [6] Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer
    Gu, Tao
    Ohashi, Rina
    Cui, Ri
    Tajima, Ken
    Yoshioka, Masakata
    Iwakami, Shinichiro
    Sasaki, Shinichi
    Shinohara, Atsuko
    Matsukawa, Takehisa
    Kobayashi, Jun
    Inaba, Yutaka
    Takahashi, Kazuhisa
    LUNG CANCER, 2009, 66 (02) : 176 - 183
  • [7] Sequential chemo-radiotherapy in non-small cell lung cancer
    Kotas, M
    Willner, J
    Flentje, M
    LUNG CANCER, 2001, 33 : S61 - S64
  • [8] Estrogen contributes to bevacizumab resistance in xenograft models of non-small cell lung cancer (NSCLC)
    Saigal, Babita
    Herynk, Mathew H.
    Cascone, Tina
    Nilsson, Monique
    Khajavi, Mehrdad
    Saintigny, Pierre
    Heymach, John V.
    CANCER RESEARCH, 2011, 71
  • [9] Drug resistance in non-small cell lung cancer
    Monzo, M
    Rosell, R
    Taron, M
    LUNG CANCER, 2001, 34 : S91 - S94
  • [10] GPR78 Regulates Autophagy and Drug Resistance in Non-small Cell Lung Cancer
    Liao, Xuqiang
    Cai, Renzhong
    Li, Gao
    Chen, Fengxia
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2023, 29 (01) : 130 - 136